Top 50 Biotechnology Startup Investors in Finland (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Business Finland
VC Fund
|
12 | Finland, United States, Sweden | Grant, Seed, Debt Financing | Software, SaaS, Biotechnology | $50k–$10M |
|
Tesi
VC Fund
|
12 | Finland, United States, Switzerland | Series A, Series B | Software, Manufacturing, Health Care | $2.4M–$46M |
|
Lifeline Ventures
VC Fund
|
10 | Finland, United States, United Kingdom | Seed, Series A, Venture - Series Unknown | Software, Health Care, Artificial Intelligence | $580k–$22M |
|
Voima Ventures
VC Fund
|
9 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $464k–$30M |
|
Springvest
VC Fund
|
8 | Finland | Series A, Venture - Series Unknown, Seed | Biotechnology, Health Care, Medical | $1.6M–$53M |
|
Finnvera Venture Capital
VC Fund
|
8 | Finland, United States, Chile | Seed, Series A | Software, Health Care, Manufacturing | $250k–$23M |
|
Butterfly Ventures
VC Fund
|
7 | Finland, Sweden, Norway | Seed, Pre-Seed | Software, Health Care, Information Technology | $110k–$4.3M |
|
Icebreaker.vc
VC Fund
|
4 | Finland, Sweden, Estonia | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | $110k–$25M |
|
Nordic Science Investments
VC Fund
|
4 | Finland, Sweden, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$4.6M |
|
Maki.vc
VC Fund
|
4 | Finland, Norway, Denmark | Seed, Series A, Pre-Seed | Software, E-Commerce, Information Technology | $578k–$37M |
|
Innovestor
VC Fund
|
4 | Finland, Sweden, Denmark | Seed, Venture - Series Unknown, Pre-Seed | Software, Health Care, Information Technology | $204k–$5.8M |
|
European Investment Bank
VC Fund
|
4 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$587M |
|
Inventure
VC Fund
|
4 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$25M |
|
VTT Ventures
VC Fund
|
4 | Finland | Seed, Venture - Series Unknown, Series A | Manufacturing, Biotechnology, Electronics | $460k–$14M |
|
Stephen Industries
VC Fund
|
3 | Finland, Sweden | Seed, Series A, Pre-Seed | Software, Health Care, Biotechnology | $330k–$45M |
|
Agronomics
VC Fund
|
3 | United States, Finland, Germany | Series A, Seed, Series B | Biotechnology, Food and Beverage, Food Processing | $894k–$55M |
|
Nordic Foodtech VC
VC Fund
|
3 | Finland, Denmark, Sweden | Seed, Pre-Seed, Series A | Biotechnology, Food and Beverage, Life Science | $610k–$18M |
|
NordicNinja VC
VC Fund
|
2 | Sweden, Finland, Estonia | Series A, Series B, Seed | Software, Information Technology, Artificial Intelligence | $1.9M–$62M |
|
Finnish Climate Fund
VC Fund
|
2 | Finland | Debt Financing, Venture - Series Unknown, Series A | Energy, Renewable Energy, Sustainability | $2.5M–$12M |
|
Sofinnova Partners
VC Fund
|
2 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
Pontos Group
VC Fund
|
2 | Finland, Estonia | Venture - Series Unknown, Seed | Apps, Mobile, Content | $6.3M–$16M |
|
Sitra
VC Fund
|
2 | Finland, The Netherlands | Grant, Series A | Health Care, Biotechnology, CleanTech | |
|
Fazer
VC Fund
|
2 | Finland | Series A, Series B, Venture - Series Unknown | Energy, Biotechnology, Food Processing | |
|
Leena Niemistö
Angel
|
2 | Finland, United States | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Software, E-Commerce | $306k–$3.5M |
|
Thames Trust
VC Fund
|
2 | United Kingdom, Finland | Series A, Seed, Series B | Software, SaaS, Music | $5M–$15M |
|
ACME Investments
VC Fund
|
2 | Finland | Series A, Venture - Series Unknown | Health Care, Biotechnology, Apps | |
|
Sto-Rahoitus
VC Fund
|
2 | Finland | Series A | Biotechnology, Medical, Software | $2M–$5.9M |
|
StartUp Health
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
Valve Ventures
VC Fund
|
2 | Finland | Seed, Series A, Venture - Series Unknown | Energy, CleanTech, Construction | $560k–$30M |
|
Creathor Ventures
VC Fund
|
2 | Germany, Switzerland, United States | Series A, Series B | Software, Health Care, Biotechnology | $2M–$30M |
|
EQT Life Sciences
VC Fund
|
2 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7.3M–$165M |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $6M–$92M |
|
Sauli Törmälä
Angel
|
2 | Finland | Seed | Life Science, Biotechnology | $598k–$1.3M |
|
David Helgason
Angel
|
1 | United States, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Artificial Intelligence | $242k–$30M |
|
MTIP AG
VC Fund
|
1 | United States, United Kingdom, Spain | Series A, Series B, Series C | Health Care, Medical, Artificial Intelligence | $1.5M–$80M |
|
Green Campus Innovations Oy
VC Fund
|
1 | Finland, Norway | Pre-Seed, Venture - Series Unknown, Seed | Energy, Manufacturing, Electric Vehicle | $616k–$2.5M |
|
Keksintösäätiö
VC Fund
|
1 | Finland | Seed | Apps, Health Care, Biotechnology | |
|
Lundbeckfonden Ventures
VC Fund
|
1 | United States, Denmark, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $10M–$95M |
|
Broadview Ventures
VC Fund
|
1 | United States, Switzerland, Canada | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $1M–$45M |
|
Ascend Capital Partners
VC Fund
|
1 | Finland, Israel, Austria | Series A, Seed, Series B | Health Care, Software, Medical Device | $1.5M–$12M |
|
CPT Capital
VC Fund
|
1 | United States, Israel, United Kingdom | Seed, Series A, Series B | Food and Beverage, Biotechnology, Food Processing | $1.3M–$226M |
|
Marten Mickos
Angel
|
1 | Finland, United States, Sweden | Seed, Series A, Convertible Note | Software, Enterprise Software, Internet | $550k–$4.5M |
|
Advent Life Sciences
VC Fund
|
1 | United States, United Kingdom, France | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Medical | $5.5M–$104M |
|
Tiger Global Management
VC Fund
|
1 | United States, India, China | Series B, Series A, Series C | Software, FinTech, Financial Services | $6.5M–$255M |
|
Avohoidon Tutkimussäätiö
VC Fund
|
1 | Finland | Seed | Medical, Health Care, Therapeutics | $591k–$957k |
|
Cor Group
VC Fund
|
1 | Finland | Seed, Pre-Seed, Series A | Health Care, Medical, Biotechnology | $2.3M–$8.7M |
|
Horizon 2020
VC Fund
|
1 | Spain, United Kingdom, Switzerland | Grant, Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $56k–$9.2M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
1 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | |
|
Conor Venture Partners
VC Fund
|
1 | Finland, United States, Sweden | Series A, Series B, Seed | Software, Analytics, Semiconductor | |
|
Takoa Invest
VC Fund
|
1 | Finland, Israel | Seed, Series B, Series C | Biotechnology, Mobile, Retail | |
| Access all 174 investors in Finland Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Grant, Seed, Debt Financing
- Geography: Finland, United States, Sweden
Investor stats
- Total investments: 235
- Round size: Seed $334k–$3.5M; Grant $50k–$10M; Debt Financing $241k–$6.5M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- STRGY AI — The strategy was never the problem. The evidence was correct, sitting in someone's hands, and it died anyway because nothing in the organization was built to carry that evidence from where it was seen to where it could be acted on, and keep it alive long enough to matter. Not a bad plan. Not bad people. A structural gap between signal andauthority that every existing tool — decks, dashboards, status meetings — is too static and too easy to ignore to actually close.STRGY exists because that gap is the default state of every organization above a certain size, and closing it has always required either a heroic individual repeating themselves for years or luck (the corporate pilot needed one person to remember "do not drop this" at the right moment, and no one did). That's not a strategy problem to solve with a better framework — it's an infrastructure problem. You need something that holds the signal, doesn't forget it, doesn't get bored repeating it, and resurfaces it automatically the moment the gap between evidence and action starts to widen. That's what a human can't do reliably at scale, and what software with real memory can.
- Coolbrook — Our RotoDynamic electric technology can cut 30% of industrial emissions annually, delivering hope at industrial scale.
- Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Series A, Series B
- Geography: Finland, United States, Switzerland
Investor stats
- Total investments: 152
- Round size: Series A $2.4M–$46M; Series B $3.1M–$37M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $177M in 2017
Portfolio highlights
- ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
- Vexlum — A #laser company providing high-power #VECSELs for #QuantumTechnology
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 201
- Round size: Seed $580k–$5.4M; Series A $2.8M–$22M; Venture - Series Unknown $616k–$17M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fresh fund, raised $464M in 2025
Portfolio highlights
- S-Transistors — S-Transistors is one of the few businesses founded on a truly novel core technology that has the potential to serve as an enabling layer for a whole industry.
- Thor Dynamics — Directed Energy Systems for Counter-Drone Defense
- Everywear Games — Everywear Games is the world’s leading wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s gamesare consistently on top of global charts.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 61
- Round size: Seed $1M–$5.9M; Pre-Seed $464k–$2.1M; Series A $3.9M–$30M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — raised $108M in 2023
Portfolio highlights
- Reduciner — Reduciner's vision to turn industrial CO₂ emissions from a liability into a valuable resource. Its technology converts captured carbon dioxide and biochar into valuable feedstocks such as carbon monoxide and activated carbon, enabling circular carbon use in emissions-intensive industries. Reduciner combines strong scientific expertise withindustrial applicability across sectors such as cement, steel, and chemicals. Its electricity-driven process allows industries to reduce emissions without major changes to existing infrastructure, offering a resilient and cost-competitive way to reduce carbon dependency while creating new value from CO₂ emissions.
- TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
- Photoncycle — The year-round solar energy system for heating and electricity
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Finland
Investor stats
- Total investments: 23
- Round size: Seed $1.6M–$7.6M; Series A $3.6M–$53M; Venture - Series Unknown $4.7M–$29M
- Lead/follow: 74% lead, 26% follow
Portfolio highlights
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- MedicubeX — MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Finland, United States, Chile
Investor stats
- Total investments: 95
- Round size: Seed $250k–$2.3M; Series A $1.8M–$23M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
- eMabler — EMabler is an EV charging infrastructure software company that develops an API-first platform used by businesses to operate, manage, and scale electric vehicle charging networks. It provides a centralized system for charge point management, billing, pricing, roaming, and energy optimization, allowing operators to control large networks of EVchargers from a single platform. The software connects charging hardware with business systems such as CRM, payment, and energy management tools through open APIs and a large library of integrations. The company focuses on enabling enterprises, such as energy utilities, parking operators, and retail businesses, to embed EV charging directly into their existing services and digital platforms rather than building standalone charging systems. This includes white-label solutions where charging is integrated into a company’s own app or customer experience under its brand.
- CHAOS — At CHAOS, we strive to democratize data and harness the power of AI and cutting-edge technology, delivering transformative location insights that empower decision-makers to design more liveable cities- sustainable, human-centered where the quality-of-life soars.
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 91
- Round size: Seed $224k–$2.1M; Pre-Seed $110k–$4.3M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $49M in 2022
Portfolio highlights
- DREV — DREV is a cleantech company manufacturing contamination control solutions for the world’s most advanced manufacturing facilities.
- Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
- Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 143
- Round size: Seed $409k–$5.4M; Pre-Seed $110k–$1.3M; Series A $3.1M–$25M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — raised $24M in 2021
Portfolio highlights
- Cytely — Cytely operationalizes biological measurement, turning microscopy into standardized, reproducible data so research teams can accelerate discovery.
- Oplane — Connect your repo. See and fix your vulnerabilities in minutes. AI-powered threat modeling - no consultants, no weeks of docs.
- Cota Robotics — Cota Robotics deploys general-purpose robots in retail stores through a Robot-as-a-Service model, integrating with existing environments without requiring changes to store layouts or infrastructure. The company automates shelf replenishment, inbound handling, and order picking using human-in-the-loop teleoperation, with autonomy increasing asdeployment data trains its models.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 17
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.9M
- Lead/follow: 88% lead, 12% follow
- Last fund: Likely still investing — raised $34M in 2024
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- mu-ray.tech — MuRay Tech generates a controlled muon beam to image inside solid metal and 3D printed pieces. Non-destructively. In minutes.
- Perfat Technologies — Perfect fats for better foods.
We partner with deep tech and brand-driven companies obsessed in challenging category norms. The Nordics are our home, but we take on a global front in spotting the unexpected - from B2B to B2C, with a sweet spot for scientific advances, strong IP, and customer understanding that looks beyond convention.We invest in early stage companies: fromtheir inception to series A and beyond. We share in the vision of founders as champions and challengers, drawing on our experiences from scaling some of the strongest tech companies ourselves.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Norway, Denmark
Investor stats
- Total investments: 103
- Round size: Seed $948k–$8.3M; Pre-Seed $578k–$2.7M; Series A $3.5M–$37M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $106M in 2024
Portfolio highlights
- Aavuus — Aavuus is building a global network of ground-based laser stations to detect and track space debris with high precision.
- Metaktik — Tactical Metasurface Antenna Solution for Defence. Ultralight Antennas for Satellites.
- Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 93
- Round size: Seed $477k–$4.5M; Pre-Seed $204k–$2M; Venture - Series Unknown $529k–$5.8M
- Lead/follow: 58% lead, 42% follow
- Last fund: Likely still investing — raised $33M in 2023
Portfolio highlights
- STRGY AI — The strategy was never the problem. The evidence was correct, sitting in someone's hands, and it died anyway because nothing in the organization was built to carry that evidence from where it was seen to where it could be acted on, and keep it alive long enough to matter. Not a bad plan. Not bad people. A structural gap between signal andauthority that every existing tool — decks, dashboards, status meetings — is too static and too easy to ignore to actually close.STRGY exists because that gap is the default state of every organization above a certain size, and closing it has always required either a heroic individual repeating themselves for years or luck (the corporate pilot needed one person to remember "do not drop this" at the right moment, and no one did). That's not a strategy problem to solve with a better framework — it's an infrastructure problem. You need something that holds the signal, doesn't forget it, doesn't get bored repeating it, and resurfaces it automatically the moment the gap between evidence and action starts to widen. That's what a human can't do reliably at scale, and what software with real memory can.
- Amplifiles — Amplifiles is a PropTech startup that turns real estate listing photos into fully branded, high-quality videos in minute, no filming or editing required. Our video engine helps agents, photographers, and marketplaces boost engagement, generate more leads, and unlock new revenue streams.
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 586
- Round size: Post-IPO Debt $18M–$587M; Debt Financing $16M–$370M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
- Skyborn Renewables — Skyborn Renewables develops, builds, and operates offshore wind projects across the full lifecycle. The company identifies sites, secures permits, structures financing, and manages engineering, procurement, and construction. Its teams plan grid connections and deliver operations and maintenance for utility-scale assets. Skyborn Renewables alsoprovides asset management, health and safety oversight, and environmental monitoring throughout project life. Services include offtake strategy and power sales support, stakeholder engagement, and supply chain coordination. The portfolio covers greenfield development, joint ventures, and acquisitions, with capabilities from early-stage studies to long-term operation. Technology work spans turbine selection, foundation design, cable layout, and digital performance analytics. Skyborn Renewables collaborates with partners to expand renewable generation and enable electrification through offshore wind energy.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 179
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $140M in 2022
Portfolio highlights
- Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
- Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
- Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Electronics
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Finland
Investor stats
- Total investments: 24
- Round size: Seed $460k–$3.3M; Series A $1.8M–$14M; Venture - Series Unknown $1.5M–$9.2M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
- Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
- Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
We fund futurebreakthroughs
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Sweden
Investor stats
- Total investments: 18
- Round size: Seed $482k–$8.2M; Pre-Seed $330k–$4.3M; Series A $8.3M–$45M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- AlixLabs — AlixLabs is a Swedish semiconductor startup, founded in 2019.
- Anferra — Turning hazardous steel waste into clean water and green energy.
- Freepress.ai — Freepress curates verified and diverse global perspectives on current news into bite-sized news stories in your language.
Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Series A, Seed, Series B
- Geography: United States, Finland, Germany
Investor stats
- Total investments: 48
- Round size: Seed $894k–$11M; Series A $6M–$47M; Series B $2.4M–$55M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Meatable — Meatable is a food production company that produces guilt-free meat. Meatable is a company that creates manufactured meat using stem cell technology. By employing pluripotent stem cells, which have the potential to transform any type of cell from muscle to fat without serum, the company's method eliminates the need to remove any tissue from ananimal, allowing consumers to have sustainable food.
- SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
- Meatly — Good Dog Food creates cultivated meat for healthy pets and a healthy planet
We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Life Science
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Denmark, Sweden
Investor stats
- Total investments: 31
- Round size: Seed $610k–$5.3M; Pre-Seed $880k–$1.9M; Series A $6.8M–$18M
- Lead/follow: 58% lead, 42% follow
- Last fund: Likely actively investing — fresh fund, raised $42M in 2024
Portfolio highlights
- Fiberdom — Fiberdom develops sustainable materials from wood fibers, focusing on plastic-free solutions. The company offers a range of compostable cutlery designed for food service and take-away applications. These products are fully recyclable and comply with European regulations, making them suitable for environmentally conscious consumers. Fiberdomemphasizes innovation in transforming wood fibers into high-performance materials, contributing to sustainability efforts in various industries. The commitment to creating eco-friendly alternatives positions Fiberdom as a key player in the materials innovation sector.
- MÖ Foods — MÖ Kaurajogu is domestic, completely herbal and above all delicious. All our products are manufactured in Central Ostrobothnia, Lohtaja.
- AquaNab Solutions — AquaNab is a biotechnology startup developing precision immunotherapies for aquaculture. The company's core platform uses alpaca-derived nanoantibodies (called AquaNabs) formulated directly into fish feed. This approach allows the therapeutic molecules to cross the fish's intestinal barrier and target pathogens from the bloodstream.
NordicNinja VC invests in startups in the Nordic-Baltic region.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: Sweden, Finland, Estonia
Investor stats
- Total investments: 56
- Round size: Seed $1.9M–$12M; Series A $5M–$30M; Series B $15M–$62M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- LiveEO — LiveEO is the leading solution provider for AI-powered satellite-based monitoring of large infrastructure networks. Trusted worldwide.
- RedpineAI — Redpine powers AI builders and autonomous agents with access to licensed, high-quality and multimodal data - securely and at scale.
- CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
The Climate Fund focuses on combating climate change, boosting low-carbon industry and promoting digitalisation.
Show more...Investment focus
- Industry: Energy, Renewable Energy, Sustainability
- Stage:Debt Financing, Venture - Series Unknown, Series A
- Geography: Finland
Investor stats
- Total investments: 21
- Round size: Debt Financing $2.5M–$12M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
- Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
- Volare — Refining food, beverage and agricultural sidestreams into protein, oil and fertilizers. Sustainable Black Soldier Fly Protein & Oil for Pet Food and Aquafeed from Finland.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 350
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
Show more...Investment focus
- Industry: Apps, Mobile, Content
- Stage:Venture - Series Unknown, Seed
- Geography: Finland, Estonia
Investor stats
- Total investments: 5
- Round size: Venture - Series Unknown $6.3M–$16M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Hintsa — Discover a better you, with methods proven in Formula 1 and Fortune 500.
- R8tech — R8 Jenny is AI HVAC technology for commercial real estate. It helps you achieve ESG goals while saving up to 30% in energy costs!
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, CleanTech
- Stage:Grant, Series A
- Geography: Finland, The Netherlands
Investor stats
- Total investments: 8
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- Headai — We help organizations succeed in a rapidly changing future by helping them find answers in large amounts of data that they can't otherwise see. Our algorithms help customers see the big picture in scattered data by revealing unknown connections and even explaining why they exist. 100% own IP, combines the strengths of Natural LanguageProcessing, self-organized learning, reinforcement learning and 20+ years experience on cognitive sciences.
- SET Ventures — SET propels founders from early growth to European scale. We invest in and grow the solutions powering the digital energy economy.
Fazer Group mission is to create taste sensations. Customer orientation, quality and operations are based.
Show more...Investment focus
- Industry: Energy, Biotechnology, Food Processing
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Finland
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
Leena Niemistö
Show more...Investment focus
- Industry: Health Care, Software, E-Commerce
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Finland, United States
Investor stats
- Total investments: 19
- Round size: Seed $306k–$3.2M; Venture - Series Unknown $2.2M–$3.5M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Rens Original — RENS Original is the World's First Sneaker made from recycled coffee and plastic. We know you've been drinking it, now it is time to wear it.
- Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Thames Trust
Show more...Investment focus
- Industry: Software, SaaS, Music
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, Finland
Investor stats
- Total investments: 5
- Round size: Series A $5M–$15M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- STEM — For makers, learners, and players. Creative computing projects, stories, and more.
- Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
- ABAKA Holdings — ABAKA is world's first digital saving and retirement enterprise SaaS platform, powered by Artificial Intelligence. Our innovative technologies enable financial institutions to power digital saving and retirement solutions and deliver scalable and affordable advice on pensions, savings and investments to their retail customers. ABAKA’s libraryof modular applications helps our enterprise clients to power conversational AI, personalised and behavioural nudges, big data insights, financial dashboards and outstanding customer experiences.Today over 9 million people have access to the ABAKA technologies through our clients, and our technologies are licensed by Tier one international banks, pension providers and asset managers across multiple countries.ABAKA’s enterprise solutions enable financial institutions to power: • Conversational AI: on pensions, savings and investments, for both fully digital and hybrid advice. The proprietary NLP models take vast quantities of user behavioural and financial data to intelligently manage a human like conversation. • Intelligent Behavioural Nudges: machine learning models to identify persona segmentation, power personalised insights and nudges to increase engagement and up-sell opportunities, across digital channels. • Digital financial dashboards: data aggregation technology powering Open Banking, Pension Tracing and Pension Dashboards. • Financial Planning Engine: retirement planning, cash flow modelling, suitability assessment, Monte-Carlo simulations for outcome & scenario driven advice
ACME Investments is a venture capital company that invests in the software, healthcare, and pharmaceutical industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Apps
- Stage:Series A, Venture - Series Unknown
- Geography: Finland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aiforia — Aiforia provides software and services for pathologists, scientists and healthcare professionals to use artificial intelligence for image analysis.
- TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Sto-Rahoitus
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Series A
- Geography: Finland
Investor stats
- Total investments: 2
- Round size: Series A $2M–$5.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aiforia — Aiforia provides software and services for pathologists, scientists and healthcare professionals to use artificial intelligence for image analysis.
- Desentum — Allergen immunotherapy that is effective, safe, patient-friendly and approved by the regulatory authorities.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 335
- Round size: Seed $100k–$4M; Pre-Seed $20k–$854k
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $31M in 2018
Portfolio highlights
- AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
- Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Valve Ventures is a Helsinki-based angel and early-stage venture investor.
Show more...Investment focus
- Industry: Energy, CleanTech, Construction
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Finland
Investor stats
- Total investments: 15
- Round size: Seed $560k–$3.2M; Series A $2.5M–$30M; Venture - Series Unknown $1.1M–$4.1M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
- QHeat — QHeat offers Clean geothermal energy solutions for sustainable built environments
- Betolar — Betolar is a materials technology company that develops circular economy solutions for the mining, metals, and construction sectors by transforming industrial sidestreams and waste materials into valuable products. Its technologies support the production of low-carbon, cement-free construction materials and enable the recovery of critical andstrategic metals from industrial waste streams. The company provides material analysis, consulting, and recipe optimization services, utilizing digitalization, data platforms, and artificial intelligence to support research, development, and industrial applications. Betolar's solutions are designed to help reduce carbon emissions, decrease reliance on virgin raw materials, and improve the utilization of industrial byproducts. Its activities span construction materials, metal extraction technologies, and circular material solutions that support more resource-efficient industrial processes.
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 96
- Round size: Series A $2M–$12M; Series B $5.1M–$30M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $90M in 2016
Portfolio highlights
- SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
- Chundsell Medicals — Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. TheProstatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 189
- Round size: Series A $7.3M–$78M; Series B $11M–$114M; Series C $12M–$165M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $282M in 2023
Portfolio highlights
- ActoGeniX — ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.
- Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
- Rotation Medical — Rotation Medical Inc. manufactures and markets a collagen scaffold for rotational cuff disease in Minnesota. The company was formerly known as Denali Medical Inc. and changed its name to Rotation Medical Inc. in March 2010. Rotation Medical was founded in 2009 and headquartered in Plymouth, Minnesota.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 141
- Round size: Series A $6M–$73M; Series B $12M–$92M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $179M in 2024
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 2
- Round size: Seed $598k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.
Show more...Investment focus
- Industry: Software, Gaming, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Denmark, Finland
Investor stats
- Total investments: 79
- Round size: Seed $1.1M–$8M; Pre-Seed $242k–$2.4M; Series A $4.3M–$30M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- ScyAI — Risk intelligence that thinks with you.
- Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
- Flow Engineering — Requirements management, made collaborative
MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 29
- Round size: Series A $1.5M–$36M; Series B $10M–$30M; Series C $9.3M–$80M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — raised $250M in 2021
Portfolio highlights
- TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
- Verifarma — Verifarma offers comprehensive, robust & high-quality services to drugs, medical products, chemical precursors, agrochemicals.
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
Provide an effective, outsourced incubation and acceleration platform .
Show more...Investment focus
- Industry: Energy, Manufacturing, Electric Vehicle
- Stage:Pre-Seed, Venture - Series Unknown, Seed
- Geography: Finland, Norway
Investor stats
- Total investments: 6
- Round size: Venture - Series Unknown $616k–$2.5M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- PikaPay — Our mission is to transform as many industries to self-service to have a better service experience for everyone.
- Akkurate — Sandvik Battery Electric Loaders and Trucks TH550B LH518B Mobile Charging Station Battery as a Service
- The Human Touch Robotics — Introducing robotics with the lightness of the human touch in realms once thought impossible.
Keksintösäätiö
Show more...Investment focus
- Industry: Apps, Health Care, Biotechnology
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 72
- Round size: Series A $10M–$50M; Series B $20M–$95M; Series C $10M–$53M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- SNIPR Biome — We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
- Women in Life Science Denmark — WiLD is a networking platform for women in senior positions in business and academia that is motivating and focused on science.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 83
- Round size: Seed $1M–$18M; Series A $1M–$20M; Series B $7M–$45M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
- Viridian Therapeutics (Formerly MiRagen Therapeutics) — Committed to developing potential best-in-class medicines for people affected by Thyroid Eye Disease and other autoimmune and rare diseases.
Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Series A, Seed, Series B
- Geography: Finland, Israel, Austria
Investor stats
- Total investments: 19
- Round size: Seed $1.5M–$9.3M; Series A $2.4M–$12M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- DriveU.auto — Transform existing terminal tractors into autonomous vehicles. Fast ROI. Continuous operation in mixed traffic.
- Pionix — PIONIX develops EVerest, a fully featured commercial open source SW platform for charging stations. With our open platform, we will provide a broad ecosystem for EV charging that can be easily extended by the open-source community and utilized by any commercial party.PIONIX as main developer of the EVerest ecosystem offers integration andsoftware update services, cloud operations and productivity & security enhancements as subscriptions.
- piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 63
- Round size: Seed $1.3M–$7M; Series A $6M–$50M; Series B $16M–$226M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
- Xias Bio — Mitigate risk with flexible licensing options. Partner with us to transform your ideas into high-performance innovations optimized for efficacy and differentiation.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Marten Mickos is the CEO of HackerOne, Inc. the leading vulnerability coordination and bug bounty platform. Previously Marten was the CEO of Eucalyptus Systems, acquired by Hewlett-Packard where he served as head of the cloud business. As the CEO of MySQL AB from 2001 to 2008, Marten grew that company from a garage start-up to the second largestopen source company in the world. Marten holds a M.Sc. in technical physics from Helsinki University of Technology in his native Finland.
Show more...Investment focus
- Industry: Software, Enterprise Software, Internet
- Stage:Seed, Series A, Convertible Note
- Geography: Finland, United States, Sweden
Investor stats
- Total investments: 15
- Round size: Seed $550k–$4.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Queer Spaces — Spaces is a group chat platform for building queer communities, and the first app to serve the entirety of the LGBTQ+ spectrum.
- Tangled — The next-generation social coding platform.
- Pandatron — With clients like SAP, Universal Pictures & Skanska, Pandatron is a startup that supports change management. We do it by scaling AI-driven coaching 1-on-1s to every employee, which also allows us to measure change.
Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 73
- Round size: Series A $5.5M–$51M; Series B $21M–$97M; Venture - Series Unknown $7M–$104M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
- Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Founded in 2001, Tiger Global Management, LLC (“Tiger Global”) is a New York-based investment firm pursuing a long-term approach to investing in leading, global public and private companies that leverage technological innovation. Tiger Global’s public equity business includes fundamentally oriented long/short, long-focused and crossoverstrategies, targeting investments in high-quality, public growth companies. The private equity business invests in early through late stage companies that pursue innovative approaches to new and existing industries, building on over 20 years of experience investing in hundreds of businesses in more than 30 countries with more than 90 portfolio company IPOs. With a strong track record investing across sectors and stages, Tiger Global aims to be a thought partner to companies and their management teams across their lifecycle in public and private markets. The Firm’s mission is to generate world-class returns for its investors and to do so in a way that makes its employees, partners and portfolio companies proud.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Series B, Series A, Series C
- Geography: United States, India, China
Investor stats
- Total investments: 1380
- Round size: Series A $6.5M–$50M; Series B $19M–$128M; Series C $30M–$255M
- Lead/follow: 58% lead, 42% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Kavak — KAVAK is an innovative company in the automotive industry that helps people acquire their own car, offering a wide range of guaranteed and certified cars.
- StrongDM — Manage access to any server, database, or Kubernetes instance in minutes. Fully auditable, replayable, secure, and drag-and-drop easy.
- OfBusiness — OFB Tech (OfBusiness) is a tech-enabled platform that facilitates raw material procurement and credit for SMEs with a focus on the manufacturing and infrastructure sectors. It integrates technology to SME's buying behavior to make available better products, at better prices, in better timelines to customers with comprehensive online andoffline support. Key raw materials include metals, chemicals, polymers, Agri commodities, petrochemicals, and building materials. OfBusiness provides SMEs access to cash flow-based financing for buying raw materials through its NBFC 'Oxyzo Financial Services'. The Company also offers a host of tech services for SMEs including BidAssist for new growth opportunities.
Avohoidon Tutkimussäätiö focuses on innovations that are based on scientific research and technologies backed by scientific breakthroughs.
Show more...Investment focus
- Industry: Medical, Health Care, Therapeutics
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 2
- Round size: Seed $591k–$957k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- StemSight — StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 6
- Round size: Seed $2.3M–$8.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Gosta Labs — Focus on care
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Nightingale Health — The most advanced health check for the health industry.
The EU framework programme for research and innovation
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: Spain, United Kingdom, Switzerland
Investor stats
- Total investments: 210
- Round size: Seed $61k–$5.8M; Grant $56k–$3.9M; Venture - Series Unknown $1.9M–$9.2M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- 3Dock — 3Dock provides cloud-based 3D printing services for companies that need additional production capacity. The platform allows team collaboration by sharing designs, tracking progress, and managing projects in real time. Printing jobs can be started remotely, enabling work from the office or home. The service provides access to professional 3Dprinting infrastructure without requiring hardware investments. It also supports large-scale prototyping and product development for multiple departments within a company.
- NovaMea — NovaMea is a cleantech startup that designs and commercializes electrochemical systems for energy storage and conversion.Its purpose is to create technology, services, and products for the storage and conversion of energy using electrochemical processes, as well as to produce, store, sell, and distribute these products and their components.
- Perciv AI — Perciv provides artificial intelligence (AI)-based software solutions to unlock the latent possibilities of radars and allow resilient and economical autonomous systems with Lidar-like performance even in severe weather circumstances.
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 497
- Lead/follow: no public data
Portfolio highlights
- BTRY — BTRY is a spin-off of EMPA and ETH and is developing the industry's first energy-dense solid-state battery, using sophisticated semiconductor manufacturing technologies.
- Zeeg — Create a customized landing page in just a few clicks and let your customers easily book appointments with you.
- viboo — viboo offers self-learning predictive control on the basis of physics-informed Machine Learning as a cloud service to smart-thermostat and building automation companies.
Conor Venture Partners is a new breed technology venture capital fund and management company. Conor invests in early-stage companies originating from Nordic and Baltic countries. Investment areas include information and communications technology, embedded software, semiconductor technology, electronics, new materials and optics.
Show more...Investment focus
- Industry: Software, Analytics, Semiconductor
- Stage:Series A, Series B, Seed
- Geography: Finland, United States, Sweden
Investor stats
- Total investments: 45
- Lead/follow: no public data
Portfolio highlights
- Neo4j — Connect data as it's stored with Neo4j. Perform powerful, complex queries at scale and speed with our graph data platform.
- Blackwood Seven — Attribute, predict and optimize the business outcome of marketing and media plans with Blackwood Seven's Unified Marketing Modeling platform.
- Verto Analytics — Verto Analytics (Verto) operates a passive metering panel that provides researchers, advertisers, and publishers the data they need to keep up with the rapid and changing pace of consumer media consumption on every app, device, service, and platform. This ongoing, longitudinal panel captures a wide breadth of behaviors—all enriched to clients’behavioral analysis or custom survey studies. Our single-source, passive metering data sets provide the information needed to understand the full digital footprint of the U.S. population. Our Data Labs are located in the US, and in Helsinki, Finland. http://www.vertoanalytics.com.
Takoa Invest is a Finnish family-owned investment company that owns and develops companies and properties with growth potential in Finland and abroad. Takoa Invest is a Finnish family-owned investment company. It owns and develops companies and properties with growth potential in Finland and abroad.
Show more...Investment focus
- Industry: Biotechnology, Mobile, Retail
- Stage:Seed, Series B, Series C
- Geography: Finland, Israel
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
- IndoorAtlas — Discover the power of indoor positioning technology with IndoorAtlas. Build innovative indoor location-based solutions using our cross-platform SDK. Explore case studies and start developing today.
Biotechnology Investor funding in Finland at a glance
Stats across 190 deals from 174 investors.
Access all 174 investors in Finland Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Investors in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 174 investors investing in Finland Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!